Virtu Financial’s Processa Pharmaceuticals PCSA Stock Holding History

Virtu Financial’s Portfolio PCSA Stock Details PCSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,634	Closed	-$8K	–	2085
2025 Q3	$8K	Sell	1,634 -2,555	-61%	-$13.5K	﹤0.01%	1352
2025 Q2	$21K	Buy	4,189 +2,460	+142%	+$16.4K	﹤0.01%	1250
2025 Q1	$16K	Buy	+1,729	New	+$26K	﹤0.01%	1136
2023 Q4	–	Sell	-23	Closed	-$3K	–	1899
2023 Q3	$3K	Sell	23 -30	-57%	-$5.67K	﹤0.01%	1170
2023 Q2	$13K	Buy	53 +27	+104%	+$7.97K	﹤0.01%	1325
2023 Q1	$7K	Buy	+26	New	+$10.5K	﹤0.01%	1376

Other funds holding PCSA

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Virtu Financial's PCSA Position: Q4 2025 in Review

Virtu Financial sold out of Processa Pharmaceuticals (PCSA) in Q4 2025, closing a stake of 1,634 shares — an estimated $8K sold.

Virtu Financial first reported a position in PCSA in Q1 2023 and held it in 6 quarters. The position peaked at $21K in Q2 2025. 10 funds tracked by Wall St. Rank hold PCSA as of Q4 2025.

Virtu Financial reported no remaining Processa Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
Virtu Financial sold 1,634 Processa Pharmaceuticals shares in Q4 2025, an estimated $8K.
Virtu Financial first reported a position in Processa Pharmaceuticals in Q1 2023 and held it in 6 quarters.
Virtu Financial's Processa Pharmaceuticals position peaked at $21K in Q2 2025.
10 funds tracked by Wall St. Rank held Processa Pharmaceuticals as of Q4 2025.

Based on Virtu Financial's 13F filing for Q4 2025, filed 23 Feb 2026.